These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19025850)

  • 1. Report of the UK DURG regional meeting on New Horizons in Pharmacovigilance.
    Barnes J
    Pharmacoepidemiol Drug Saf; 2000 Sep; 9(5):429-34. PubMed ID: 19025850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a training course on pharmacovigilance in Sub-Saharan Africa.
    Adverse Drug Reaction and Medicine Review Committee
    Pharmacoepidemiol Drug Saf; 2000 Mar; 9(2):133-8. PubMed ID: 19025813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance in European pharmacovigilance: how compliant is compliant?
    Koster Phd MC; Teeuw Phd B; Cockburn Mb Chb Mrcgp Ffpm I
    Pharmacoepidemiol Drug Saf; 2000 Nov; 9(6):473-8. PubMed ID: 19025853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UK.
    Norman P
    IDrugs; 1999 Jul; 2(7):659-63. PubMed ID: 16127635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The founding of the EURO-DURG, the European Drug Utilization Research Group.
    Schubert I
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):410-3. PubMed ID: 8880293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the UK DURG National Meeting on 13 December 1996 held at the Royal Society of Medicine in London.
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):31-8. PubMed ID: 15073744
    [No Abstract]   [Full Text] [Related]  

  • 7. New initiatives for pharmacovigilance in South Korea: introducing the Korea Institute of Drug Safety and Risk Management (KIDS).
    Shin JY; Jung SY; Ahn SH; Lee SH; Kim SJ; Seong JM; Chung SY; Park BJ
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1115-22. PubMed ID: 25251052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1st Meeting of EURO DURG, the European Drug Utilization Research Group. Hungary, 27-30 June 1996. Abstracts.
    Eur J Clin Pharmacol; 1997; 52(3):A19-28. PubMed ID: 9273307
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigation by young members--comprehensive remarks as a chairman].
    Kubota T
    Rinsho Byori; 2014 Jul; 62(7):719-20. PubMed ID: 25669043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.
    Bahri P; Mol PG; Théophile H; Edwards IR; Hugman BP
    Drug Saf; 2011 Oct; 34(10):881-2. PubMed ID: 21879782
    [No Abstract]   [Full Text] [Related]  

  • 11. Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activities.
    Brown Bmedsci Mb Chb Mrcgp Ffpm E; Douglas Bsc S
    Pharmacoepidemiol Drug Saf; 2000 Nov; 9(6):479-89. PubMed ID: 19025854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UK.
    Lynn E; Layton D; Shakir S
    Drug Saf; 2011 Jan; 34(1):89-91. PubMed ID: 21142274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance teaching in UK undergraduate pharmacy programmes.
    Smith MP; Webley SD
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):223-8. PubMed ID: 22745046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
    Awada Z; Zgheib NK
    Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance and communicating safety information.
    Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics, molecular imaging, bioinformatics, and bio-nano-info integration are synergistic components of translational medicine and personalized healthcare research.
    Yang JY; Yang MQ; Arabnia HR; Deng Y
    BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):I1. PubMed ID: 18831773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European pharmacovigilance: increasingly outsourced to drug companies.
    Prescrire Int; 2014 Dec; 23(155):302-3, 305-7. PubMed ID: 25629153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal drug delivery. 7-8 June 1999, London, UK.
    Barnhart K
    IDrugs; 1999 Aug; 2(8):756-9. PubMed ID: 16127648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report on the Na+/H+ Exchanger Satellite Meeting at the 53rd Annual Meeting of the Canadian Society of Biochemistry, Molecular and Cellular Biology.
    Alexander RT; Fliegel L
    Biochem Cell Biol; 2011 Apr; 89(2):85-6. PubMed ID: 21455260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.